申请人:Merck & Co., Inc.
公开号:US04665094A1
公开(公告)日:1987-05-12
Hydroxyalkyl-phenoxy-propan-2-olamines and novel esters thereof are oculoselective .beta.-blockers useful in the treatment of elevated intraocular pressure with little or no effect on the pulmonary or cardiovascular system.
羟基烷基苯氧基丙烷-2-醇胺及其新型酯类是眼部选择性β-受体阻滞剂,可用于治疗眼内压升高,对肺部或心血管系统几乎没有影响。